Invida Holdings Private Limited, the leading biopharmaceutical commercialization company in Asia-Pacific, is pleased to announce a name change to A. Menarini Asia-Pacific Holdings Pte. Ltd. ("Menarini Asia-Pacific") effective immediately.
Established in 1986, Menarini Biotech is part of Menarini Ricerche and is headquartered in Menarini's Scientific Campus in Pomezia, Rome.
To further expand its research capabilities into the area of Biotechnology, Menarini Biotech introduced full product research, development and production capabilities in 2003.
Today, Menarini Biotech develops and manufactures bio-pharmaceuticals, using both mammalian cells and microbial production systems.
Menarini Biotech is licensed by The Italian Medicines Agency (AIFA) for the manufacture of Clinical Supply for Human Use and complies with the highest international quality and regulatory standards.
Menarini Biotech has expertise in the following therapeutic areas:
- Cardiovascular diseases
- Pain – Inflammation
- Gastrointestinal diseases
- Metabolic diseases
For more information, please visit: http://www.menarini-biotech.com/